Abstract
In systemic autoimmune rheumatic diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), the interaction between hyperactive T cells and B cells causes a dysregulated production of autoantibodies that can lead to tissue damage, with subsequent impaired organ function and disability. The available information on the immune cells that participate in this process has led to the development of several approaches that can influence disease course. One of these approaches uses immunomodulatory peptides that mimic selected sequences involved in the interaction between T and B cells. Preclinical studies in animal models have given encouraging results, and synthetic peptidebased intervention in human autoimmune rheumatic diseases is now approaching translational work into clinical settings.
Keywords: Systemic autoimmunity, synthetic peptides, immune modulation
Current Clinical Pharmacology
Title: Mimicking Self-Antigens with Synthetic Peptides in Systemic Autoimmune Rheumatic Diseases
Volume: 4 Issue: 2
Author(s): Chunlin Cai and Antonio La Cava
Affiliation:
Keywords: Systemic autoimmunity, synthetic peptides, immune modulation
Abstract: In systemic autoimmune rheumatic diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), the interaction between hyperactive T cells and B cells causes a dysregulated production of autoantibodies that can lead to tissue damage, with subsequent impaired organ function and disability. The available information on the immune cells that participate in this process has led to the development of several approaches that can influence disease course. One of these approaches uses immunomodulatory peptides that mimic selected sequences involved in the interaction between T and B cells. Preclinical studies in animal models have given encouraging results, and synthetic peptidebased intervention in human autoimmune rheumatic diseases is now approaching translational work into clinical settings.
Export Options
About this article
Cite this article as:
Cai Chunlin and Cava La Antonio, Mimicking Self-Antigens with Synthetic Peptides in Systemic Autoimmune Rheumatic Diseases, Current Clinical Pharmacology 2009; 4 (2) . https://dx.doi.org/10.2174/157488409788184936
DOI https://dx.doi.org/10.2174/157488409788184936 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Current Anti-Inflammatory Therapies and the Potential of Secretory Phospholipase A2 Inhibitors in the Design of New Anti-Inflammatory Drugs: A Review of 2012 - 2018
Current Medicinal Chemistry Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
Current Drug Discovery Technologies Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism AlphaScreen™ Kinase HTS Platforms
Current Medicinal Chemistry <i>In vivo</i> Anticancer Potential of Hydroxamic Acid Derivatives
Current Topics in Medicinal Chemistry Targeting Molecular Imaging Approach for Detection of Infection and Inflammation by Diagnostic Nuclear Medicine Techniques
Current Medical Imaging Synthetic and Medicinal Prospective of Structurally Modified Curcumins
Current Topics in Medicinal Chemistry Citrullinated Peptides in the Diagnosis of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Engineering Approaches to Develop the Next Generation of Antibodies to Respiratory Targets
Inflammation & Allergy - Drug Targets (Discontinued) Probiotics, Immune Function, Infection and Inflammation: A Review of the Evidence from Studies Conducted in Humans
Current Pharmaceutical Design Light Directed Gene Transfer by Photochemical Internalisation
Current Gene Therapy Bleomycin and its Role in Inducing Apoptosis and Senescence in Lung Cells - Modulating Effects of Caveolin-1
Current Cancer Drug Targets Effects of Chrisotherapeutic Gold Compounds on Prostaglandin E2 Production
Current Drug Targets - Inflammation & Allergy Molecular Targets of Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Editorial: Pulmonary Involvement in Systemic Disorders
Current Drug Targets - Inflammation & Allergy NMR Based Metabolomics: An Exquisite and Facile Method for Evaluating Therapeutic Efficacy and Screening Drug Toxicity
Current Topics in Medicinal Chemistry Chemical and Bioactive Diversities of the Genus Chaetomium Secondary Metabolites
Mini-Reviews in Medicinal Chemistry Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis
Current Drug Targets